We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+11.41%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$18.5B
AUM Growth
+$2.73B
Cap. Flow
+$1.18B
Cap. Flow %
6.38%
Top 10 Hldgs %
17.08%
Holding
1,449
New
438
Increased
447
Reduced
240
Closed
319

Top Buys

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$224M
2
BA icon
Boeing
BA
+$182M
3
BAC icon
Bank of America
BAC
+$178M
4
C icon
Citigroup
C
+$126M
5
JPM icon
JPMorgan Chase
JPM
+$120M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$363M
2
BP icon
BP
BP
+$245M
3
GSK icon
GSK
GSK
+$165M
4
NOK icon
Nokia
NOK
+$142M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$142M

Sector Composition

Rank Sector Weight
1 Financials 19.33%
2 Technology 18.71%
3 Healthcare 16.5%
4 Communication Services 12.26%
5 Industrials 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
1301
Vanda Pharmaceuticals
VNDA
$302M
-13,044
Closed -$143K
VRTX icon
1302
Vertex Pharmaceuticals
VRTX
$126B
-262,051
Closed -$19.9M
VZ icon
1303
Verizon
VZ
$196B
-1,049,081
Closed -$49M
WBA
1304
DELISTED
Walgreens Boots Alliance
WBA
-82,413
Closed -$4.43M
WEC icon
1305
WEC Energy
WEC
$35.1B
-13,646
Closed -$551K
WNC icon
1306
Wabash National
WNC
$527M
-65,085
Closed -$759K
WTRG icon
1307
Essential Utilities
WTRG
$11.4B
-3,041
Closed -$75K
WTS icon
1308
Watts Water Technologies
WTS
$13.1B
-1,204
Closed -$68K
WYNN icon
1309
Wynn Resorts
WYNN
$10.6B
-330,386
Closed -$52.2M
XPO icon
1310
XPO
XPO
$23.7B
-38,100
Closed -$286K
NPKI
1311
NPK International
NPKI
$1.14B
-398,313
Closed -$5.04M
JBTM
1312
JBT Marel
JBTM
$6.39B
-1,272
Closed -$32K
B
1313
DELISTED
Barnes Group Inc.
B
-1,597
Closed -$56K
MRO
1314
DELISTED
Marathon Oil Corporation
MRO
-1,447,677
Closed -$50.5M
SWN
1315
DELISTED
Southwestern Energy Company
SWN
-16,077
Closed -$585K
CBD
1316
DELISTED
Companhia Brasileira de Distribuicao
CBD
-290,709
Closed -$13.4M
MDRX
1317
DELISTED
Veradigm Inc. Common Stock
MDRX
-787,561
Closed -$11.7M
IMGN
1318
DELISTED
Immunogen Inc
IMGN
-61,589
Closed -$1.05M
SGEN
1319
DELISTED
Seagen Inc. Common Stock
SGEN
-108,028
Closed -$4.74M
GHL
1320
DELISTED
Greenhill & Co., Inc.
GHL
-6,018
Closed -$300K
NXGN
1321
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-134,482
Closed -$2.92M
CIR
1322
DELISTED
CIRCOR International, Inc
CIR
-2,560
Closed -$159K
PDCE
1323
DELISTED
PDC Energy, Inc.
PDCE
-2,651
Closed -$158K
BSMX
1324
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-352,210
Closed -$4.87M
VIVO
1325
DELISTED
Meridian Bioscience Inc
VIVO
-13,956
Closed -$330K

Similar funds

Arrowstreet Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Arrowstreet Capital held 1,449 positions worth $18.5B, up 17% from $15.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Arrowstreet Capital deployed $1.18B of net new capital in Q4 2013, opening 438 new positions and adding to 447 existing holdings. Its largest new stake was Bank of America: 11,999,441 shares worth $187M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 9.3% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was GSK, an estimated $165M trimmed.

  • Arrowstreet Capital's largest Q4 2013 buy was Bank of America: 11,999,441 shares worth $187M.
  • Arrowstreet Capital added most to Vodafone in Q4 2013, an estimated $224M increase.
  • Arrowstreet Capital's biggest Q4 2013 reduction was GSK, cutting an estimated $165M.
  • Arrowstreet Capital fully exited Philip Morris in Q4 2013, selling an estimated $363M.
  • Arrowstreet Capital's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2013.
  • Arrowstreet Capital opened 438 new positions and closed 319 in Q4 2013.
  • Arrowstreet Capital's portfolio value rose 17% quarter-over-quarter to $18.5B.

Based on Arrowstreet Capital's 13F filing for Q4 2013, filed 14 Feb 2014.